TG THERAPEUTICS INC

Insider gifting of 5,950 TG Therapeutics shares showcases how philanthropy can boost ESG appeal while maintaining insider confidence, offering investors a unique blend of social impact and biotech growth potential.

Insider buys reveal TG Therapeutics’ confidence: CFO’s long‑term stake and CEO’s open‑market purchase hint at undervaluation and future growth amid market volatility.